From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
about
Targeting innate immunity for neurodegenerative disorders of the central nervous systemBispecific antibodies and their applicationsInterleukin-35: Expanding Its Job ProfileThe Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi InfectionBoosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosisInnate Immunity Fights Alzheimer's DiseaseInfluence of genetic polymorphisms (IL-10/CXCL8/CXCR2/NFκB) on the susceptibility of autoimmune rheumatic diseasesS100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4An anti-interleukin-2 receptor drug attenuates T- helper 1 lymphocytes-mediated inflammation in an acute model of endotoxin-induced uveitisIL-37 inhibits inflammasome activation and disease severity in murine aspergillosisRational Structure-Based Rescaffolding Approach to De Novo Design of Interleukin 10 (IL-10) Receptor-1 MimeticsObesity, inflammation, and lung injury (OILI): the good.Inflammation early in life is a vulnerability factor for emotional behavior at adolescence and for lipopolysaccharide-induced spatial memory and neurogenesis alteration at adulthood.T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response.Regulatory T cells in multiple sclerosis and myasthenia gravis.Significant reduction of peripheral blood interleukin-35 and CD4+EBI3+ T cells, which are negatively correlated with an increase in the plasma IL-17 and cTnI level, in viral myocarditis patientsIn vivo immune signatures of healthy human pregnancy: Inherently inflammatory or anti-inflammatory?Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndromeKinetic analysis of the immunity in a pregnant patient infected with avian influenza H7N9β-Arrestin 2 negatively regulates Toll-like receptor 4 (TLR4)-triggered inflammatory signaling via targeting p38 MAPK and interleukin 10.Effects of ceftriaxone on systemic and central expression of anti- and pro-inflammatory cytokines in alcohol-preferring (P) rats exposed to ethanol.Targeting regulatory T cells to improve vaccine immunogenicity in early life.Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signalingImmunotherapeutic strategies in autoimmune uveitisHuman cell-based artificial antigen-presenting cells for cancer immunotherapy.Mechanisms and applications of interleukins in cancer immunotherapy.Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular functionDifferences in inflammatory markers between nulliparous women admitted to hospitals in preactive vs active labor.Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunityChronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.High IL-35 pleural expression in patients with tuberculous pleural effusion.Elevated Serum Level of IL-35 Associated with the Maintenance of Maternal-Fetal Immune Tolerance in Normal PregnancyThe Expression of Notch/Notch Ligand, IL-35, IL-17, and Th17/Treg in Preeclampsia.Involvement of Visceral Adipose Tissue in Immunological Modulation of Inflammatory Cascade in PreeclampsiaRAGE and TGF-β1 Cross-Talk Regulate Extracellular Matrix Turnover and Cytokine Synthesis in AGEs Exposed Fibroblast CellsEosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge.Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members.TGF-β3 Inhibits Antibody Production by Human B Cells.IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice.A Novel Peroxisome Proliferator-activated Receptor (PPAR)γ Agonist 2-Hydroxyethyl 5-chloro-4,5-didehydrojasmonate Exerts Anti-Inflammatory Effects in Colitis
P2860
Q26744219-413CB06E-916D-45D8-9C85-AACD72171084Q26774024-AD1B5525-8EF4-46E5-8224-8FCB27590451Q26829619-E364D4DF-11B3-477A-9611-75E1403DC113Q26829884-7B9FFEDD-6177-4DE1-B24D-1A924DE1B1DFQ27315911-5806FDC4-AB39-4B37-A399-509351F81AB0Q28081826-790B32A0-D650-4D0F-97C5-CD70BAFE652FQ28086939-173FFF30-8262-4C6B-A83F-CF3BFC78AD57Q28240188-0A1FAF25-C245-4EE0-8A92-93840C40536EQ28540312-D5E72B11-2B7E-44AE-8130-3480ECF3866FQ28544789-82333B24-2148-45DE-A184-D9C50A738857Q28551658-F5A80289-01AA-4776-BC89-A896F9E82E04Q30363313-55E4EF50-23F8-4E58-8783-B46F55B8A601Q30430203-79F2B543-C80A-4E8A-8915-9CA7C8C89CC2Q33595572-8002C768-8141-41CB-A520-A93FE8EA00C5Q33784969-17EA1ED5-C4BC-4A8F-B5D8-2AE297A1BB52Q33797114-9236D79A-864B-485E-8F96-17F63BD3DC16Q33821861-D35A6B7E-9095-4DDD-A675-EC70583579B3Q33917011-91A869BF-CB19-4F27-9FB3-5B89AF974967Q34042221-284BDE7A-E017-446D-993E-D5D9E57F862BQ34044736-409A3F23-A0A2-41F6-9274-3F0AD52A3E97Q34048165-F640F2BF-DCD1-4A3C-956D-35E9911DFD18Q34164169-AF5F7207-53D9-423F-A98C-3B34E12C87D7Q34202453-5FAD2C06-EE2B-4E95-870A-A85E5901A96AQ34274950-22FCFED8-031B-4CBE-9C5F-4CA2D5695451Q34391263-9870EA1A-9AC7-490F-A287-1B203856D867Q34458290-9CA81DDE-A726-4D06-A8D1-A6B8BD487508Q34538722-8A0ECC40-FD81-4FF2-A843-7FA6AE4B6BDBQ34765789-DE7396C5-E1A1-40BE-9553-FC4EB8B5DC1DQ34984596-B12FF4F2-0205-479C-BF1C-E0B6742798B3Q35100546-B22F93C1-EB77-4025-8EE8-4D5B8A514E6BQ35605534-4F637463-A800-4261-BD53-512D3BE32474Q35652752-F8F85BF8-A507-4ECA-9C30-BAF5AEA29652Q35657090-0EB61B63-5102-4AC0-ADB8-07F5C5C71560Q35690758-5DF28D73-299E-4940-ADE7-C18B6034FE5DQ35970395-3D0047DA-526A-40DC-9799-1FA3F9EDA366Q36105237-C4B14D14-9E32-40F7-B3C1-30D947B7D90FQ36198449-E65905F9-1665-4DAC-A640-5B055686517BQ36239510-9FFE6BD2-13F3-4B30-BFA2-3A597907A13FQ36254533-167F5459-08F1-4611-9D52-915A0BA2287FQ36283368-0608CE0D-DDF4-453F-8328-75EC544DFA8D
P2860
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
@ast
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
@en
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
@nl
type
label
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
@ast
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
@en
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
@nl
prefLabel
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
@ast
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
@en
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
@nl
P2860
P3181
P356
P1433
P1476
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
@en
P2093
Virginia Pascual
P2860
P304
P3181
P356
10.1038/NI.2406
P407
P577
2012-10-01T00:00:00Z